Clinical Reference Laboratory, Inc.
Records under this name other than the patents Clinical Reference Laboratory, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Back to Clinical Reference Laboratory, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,738,934 | Genetic markers of mental illness Lapsed on the fee record Ended Aug 22, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 22, 2025 | From the USPTO record |
| US 7,985,551 | Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Lapsed on the fee record Ended Jul 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 26, 2023 | From the USPTO record |
| US 7,972,793 | Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Lapsed on the fee record Ended Jul 5, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 5, 2023 | From the USPTO record |
| US 7,951,542 | Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Lapsed on the fee record Ended May 31, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 31, 2023 | From the USPTO record |
| US 7,951,543 | Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Lapsed on the fee record Ended May 31, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 31, 2023 | From the USPTO record |
| US 7,932,042 | Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature Lapsed on the fee record Ended Apr 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2023 | From the USPTO record |
| US 7,442,497 | Methods of determining chronic hepatitis C infection Term ended Term ended Jan 18, 2022 · From the USPTO record | Term ended | Term ended Jan 18, 2022 | From the USPTO record |
| US 7,094,558 | Methods of determining active levels of drugs in fluid samples Term ended Term ended Nov 9, 2021 · From the USPTO record | Term ended | Term ended Nov 9, 2021 | From the USPTO record |
| US 4,572,834 | Biologic and method of preparing same Formerly held Term ended Term ended no later than Feb 25, 2006 · Low confidence | Term ended | Term ended no later than Feb 25, 2006 | Low confidence |
| US 4,687,665 | Biologic and method of preparing same Formerly held Term ended Term ended no later than Aug 18, 2007 · Low confidence | Term ended | Term ended no later than Aug 18, 2007 | Low confidence |